Published

Long-term follow-up of psilocybin-facilitated smoking cessation.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: The American journal of drug and alcohol abuse
Date: 2017-01-01
Source: PubMed
DOI: 10.3109/00952990.2016.1170135
PubMed: 27441452

Authors

Johnson MW Garcia-Romeu A Griffiths RR

Watch author

Derived topics and classifications

psilocybin Addiction Receptor Pharmacology Spirituality Mystical Experience Other

Citation graph

0 referenced DOIs found in stored source metadata. 19 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin-assisted psychotherapy for substance use disorders as a complex intervention: A systematic review of efficacy, mechanisms and psychotherapeutic frameworks2026-08-17 Modeled Long-Term Effects of Psilocybin on Dynamic Activity and Effective Connectivity of Fronto-Striatal-Thalamic Circuits2026-07-01 Psilocybin: Chemical Foundations and Emerging Therapeutic Potential2026-06-01 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01 Psilocybin Decreases Preference for Large Rewards Accompanied by Increased Activity of Parvalbumin Neurons With Perineuronal Nets in the Medial Prefrontal Cortex2026-06-01 Psilocybin-assisted cognitive behavioral therapy for major depressive disorder: A pilot trial2026-06-01 The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes2026-04-21 Sex-specific increased reactivity of the PVT and prolonged PVT→CeA circuit engagement following psilocin administration2026-04-10 Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications2026-04-01 Psilocin fosters neuroplasticity in iPSC-derived human cortical neurons2026-03-27 Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)2026-03-26 Psilocybin or Nicotine Patch for Smoking Cessation2026-03-10 Psilocybin and psilocin regulate microglial immunomodulation and support neuroplasticity via serotonergic and AhR signaling2025-06-01 Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans2025-04-21 In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin2024-04-29 The molecular basis of the antidepressant action of the magic mushroom extract, psilocin2023-07-01 Development and validation of an LC-MS/MS method for the bioanalysis of psilocybin’s main metabolites, psilocin and 4-hydroxyindole-3-acetic acid, in human plasma2021-02-01 Direct Phosphorylation of Psilocin Enables Optimized cGMP Kilogram-Scale Manufacture of Psilocybin2020-07-14 Long-term follow-up of psilocybin-facilitated smoking cessation.2017-01-01

Related papers

The potential of 5-methoxy-N,N-dimethyltryptamine in the treatment of alcohol use disorder: A first look at therapeutic mechanisms of action.Addiction biology · 2024-04-01 What can we learn from the history of research on psychedelic drugs in the addictions?Addiction · 2021-08-12 "I've learned that I'm open-minded to this possibility": A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke.Addiction science & clinical practice · 2025-07-21 Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile AnalysisInternational Journal of Mental Health and Addiction · 2025-04-24 Unique Psychological Mechanisms Underlying Psilocybin Therapy Versus Escitalopram Treatment in the Treatment of Major Depressive DisorderInternational Journal of Mental Health and Addiction · 2024-03-07 Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)ClinicalTrials.gov · 2026-07-30 Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical TrialClinicalTrials.gov · 2026-07-28 Computationally, Electrophysiologically, and Qualitatively Characterizing Serotonergic Psychedelics; Transdiagnostic Therapeutic and Pro-Psychotic EffectsClinicalTrials.gov · 2026-07-09